Orange Book product · Brand (NDA)
TENORMIN
ATENOLOL
At a glance
Apr 09, 1990
Approved
Brand (NDA)
Application
AB
TE code
None
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Apr 09, 1990
36 yr 9 mo ago
Today
Pharmaceutical detail
Active ingredient
ATENOLOL
Strength
25MG
Dosage form
TABLET
Route
ORAL
TE code
AB
Application
NDA 018240
Product number
004
Marketing status
RX
Reference listed drug (RLD)
Yes
Reference standard (RS)
No
Active-ingredient family
View full familyThis is a reference-listed drug (RLD) — the basis for generic (ANDA) applications. Other products sharing this ingredient are listed below.
- 1989TENORMINBrand (NDA)
NDA 019058 · ASTRAZENECA
- 2019ATENOLOLGeneric (ANDA)
ANDA 213136 · UNICHEM
- 2009ATENOLOLGeneric (ANDA)
ANDA 078254 · NORTHSTAR HLTHCARE
- 2007ATENOLOLGeneric (ANDA)
ANDA 078512 · AUROBINDO PHARMA
- 2007ATENOLOLGeneric (ANDA)
ANDA 078210 · SUN PHARM INDS INC
- 2006ATENOLOLGeneric (ANDA)
ANDA 077877 · IPCA LABS LTD
- 2006ATENOLOLGeneric (ANDA)
ANDA 077443 · UNIQUE
- 2005ATENOLOLGeneric (ANDA)
ANDA 076900 · ZYDUS PHARMS USA
- 2004ATENOLOLGeneric (ANDA)
ANDA 076907 · ABLE
- 2004ATENOLOLGeneric (ANDA)
ANDA 074056 · TEVA
- 1999ATENOLOLGeneric (ANDA)
ANDA 073457 · MYLAN
- 1998ATENOLOLGeneric (ANDA)
ANDA 074126 · MYLAN
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
